Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial...
4 KB (353 words) - 01:55, 22 December 2023
(subsidiary of Johnson & Johnson; 1879– ) Medac (1970– ) Medherant (2015– ) Medivir (1988– ) Medochemie (1976– ) Meiji Seika (1916– ) Melinta (2000– ) Melior...
34 KB (2,175 words) - 05:58, 20 September 2024
treatment for hepatitis C virus". Food and Drug Administration. Nov 22, 2013. "Medivir: Simeprevir has been approved in Japan for the treatment of genotype 1...
54 KB (6,597 words) - 13:33, 7 October 2024
unclear. Simeprevir is a HCV protease inhibitor. Simeprevir was developed by Medivir AB and Janssen Pharmaceutica. It was approved for medical use in the United...
26 KB (2,541 words) - 05:04, 4 January 2024
stroke. Other cathepsin K inhibitors are in various stages of development. Medivir has a cathepsin K inhibitor, MIV-711 (L-006235), in Phase IIa clinical...
15 KB (1,713 words) - 02:14, 4 September 2024
Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It...
2 KB (78 words) - 21:34, 15 March 2024
prevention of cartilage damage but did not show reduction in patient pain. Medivir Invossa-K (Transforming Growth Factor- β) Cell/Gene therapy Human studies...
30 KB (2,378 words) - 14:30, 23 August 2024
Pharmacia Upjohn (1995-97), Vice President of Pharmaceutical Development for Medivir AB (1997-2006), Chief Medical Officer at Algeta AB (2006-07), Chief Executive...
16 KB (1,254 words) - 18:16, 3 October 2024